Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-07-25 11:57 Tx date 2024-07-23 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
675,000 | |
Filed 2022-09-27 11:28 Tx date 2022-09-26 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+175,000 vol |
475,000 | |
Filed 2021-10-14 13:27 Tx date 2021-10-13 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,000
-5,000 vol $0.20 each |
645,000 | |
Filed 2021-07-15 15:27 Tx date 2021-06-24 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
Filed 2021-07-15 13:47 Tx date 2021-06-24 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
Filed 2021-07-15 13:47 Tx date 2021-06-24 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-15 13:37 Tx date 2021-06-24 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
275,000 | ||
Filed 2021-07-15 13:37 Tx date 2021-06-24 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
650,000 | ||
Filed 2021-07-15 13:31 Tx date 2021-06-23 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-15 13:31 Tx date 2021-06-23 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-15 13:23 Tx date 2021-06-25 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-15 13:23 Tx date 2021-06-25 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 15:29 Tx date 2021-06-14 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 15:26 Tx date 2021-06-14 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 13:04 Tx date 2021-06-14 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 15:29 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
275,000 | ||
Filed 2021-06-24 15:26 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-24 13:04 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
650,000 |